KAINOS Laboratories (TSE:4556) Asset Turnover: 0.29 (As of Mar. 2026)


TSE:4556 KAINOS Laboratories Inc TSE:4556
39 GF Score
Price 円2,268.00
GF Value 円1,281.99
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is KAINOS Laboratories Asset Turnover?

KAINOS Laboratories TSE:4556 39 Asset Turnover is 0.29 as of Mar. 2026. GuruFocus rates TSE:4556 with a GF Score™ of 39/100 and a GF Value™ of 円1,281.99 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. KAINOS Laboratories's Revenue for the six months ended in Mar. 2026 was 円2,712 Mil. KAINOS Laboratories's Total Assets for the quarter that ended in Mar. 2026 was 円9,234 Mil. Therefore, KAINOS Laboratories's Asset Turnover for the quarter that ended in Mar. 2026 was 0.29.

Asset Turnover is linked to ROE % through Du Pont Formula. KAINOS Laboratories's annualized ROE % for the quarter that ended in Mar. 2026 was 4.03%. It is also linked to ROA % through Du Pont Formula. KAINOS Laboratories's annualized ROA % for the quarter that ended in Mar. 2026 was 3.09%.


KAINOS Laboratories  (TSE:4556) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

KAINOS Laboratories's annulized ROE % for the quarter that ended in Mar. 2026 is

ROE %**(Q: Mar. 2026 )
=Net Income/Total Stockholders Equity
=285.766/7093.6575
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(285.766 / 5423.43)*(5423.43 / 9233.881)*(9233.881/ 7093.6575)
=Net Margin %*Asset Turnover*Equity Multiplier
=5.27 %*0.5873*1.3017
=ROA %*Equity Multiplier
=3.09 %*1.3017
=4.03 %

Note: The Net Income data used here is two times the semi-annual (Mar. 2026) net income data. The Revenue data used here is two times the semi-annual (Mar. 2026) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

KAINOS Laboratories's annulized ROA % for the quarter that ended in Mar. 2026 is

ROA %(Q: Mar. 2026 )
=Net Income/Total Assets
=285.766/9233.881
=(Net Income / Revenue)*(Revenue / Total Assets)
=(285.766 / 5423.43)*(5423.43 / 9233.881)
=Net Margin %*Asset Turnover
=5.27 %*0.5873
=3.09 %

Note: The Net Income data used here is two times the semi-annual (Mar. 2026) net income data. The Revenue data used here is two times the semi-annual (Mar. 2026) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


KAINOS Laboratories Asset Turnover Related Terms


KAINOS Laboratories Asset Turnover Historical Data

* Premium members only.

The historical data trend for KAINOS Laboratories's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

KAINOS Laboratories Asset Turnover Chart

KAINOS Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Asset Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.64 0.63 0.61 0.61 0.60

KAINOS Laboratories Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.31 0.31 0.31 0.31 0.29

TSE:4556 vs ISRG, BDX, MDLN: Asset Turnover Comparison

For the Medical Instruments & Supplies subindustry, KAINOS Laboratories's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


KAINOS Laboratories Asset Turnover vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, KAINOS Laboratories's Asset Turnover distribution charts can be found below:

* The bar in red indicates where KAINOS Laboratories's Asset Turnover falls into.


TSE:4556
39GF Score
KAINOS Laboratories Inc TSE:4556
Asset Turnover is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

KAINOS Laboratories Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

KAINOS Laboratories's Asset Turnover for the fiscal year that ended in Mar. 2026 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Mar. 2026 )/( (Total Assets (A: Mar. 2025 )+Total Assets (A: Mar. 2026 ))/ count )
=5479.789/( (8785.144+9566.85)/ 2 )
=5479.789/9175.997
=0.60

KAINOS Laboratories's Asset Turnover for the quarter that ended in Mar. 2026 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Mar. 2026 )/( (Total Assets (Q: Sep. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=2711.715/( (8900.912+9566.85)/ 2 )
=2711.715/9233.881
=0.29

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.

Frequently Asked Questions Learn more about Asset Turnover →
What does a Asset Turnover of 0.29 mean?
KAINOS Laboratories (TSE:4556) has a Asset Turnover of 0.29 as of Mar. 2026. Asset turnover equals current-period sales over average total assets over the past two periods. View historical data on KAINOS Laboratories and its competitors.
Is KAINOS Laboratories' Asset Turnover too high?
KAINOS Laboratories' current Asset Turnover is 0.29. Overall, KAINOS Laboratories has a GF Score™ of 39/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does KAINOS Laboratories' Asset Turnover compare to ISRG and BDX?
KAINOS Laboratories' Asset Turnover of 0.29 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Asset Turnover for a Medical Devices & Instruments company?
A good Asset Turnover depends on the Medical Devices & Instruments industry context. However, Asset Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Asset Turnover mean?
A high Asset Turnover can signal that a stock is expensive relative to its fundamentals. Asset turnover equals current-period sales over average total assets over the past two periods. View historical data on KAINOS Laboratories and its competitors. KAINOS Laboratories's current Asset Turnover is 0.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is KAINOS Laboratories stock overvalued right now?
Based on GuruFocus' analysis, KAINOS Laboratories (TSE:4556) is currently considered Significantly Overvalued. The stock's GF Value™ is 円1,281.99, compared to a current price of 円2,268.00 — trading 76.9% above its estimated fair value. The current Asset Turnover is 0.29. KAINOS Laboratories' overall GF Score™ is 39/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Asset Turnover calculated?
Asset Turnover is calculated from a company's financial statements. For KAINOS Laboratories (TSE:4556), the current Asset Turnover is 0.29 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is KAINOS Laboratories (TSE:4556) Overvalued in 2026?

Based on GuruFocus' analysis, KAINOS Laboratories stock appears to be overvalued. The current stock price of 円2,268.00 is trading 76.9% above its estimated GF Value™ of 円1,281.99. GuruFocus considers KAINOS Laboratories to be Significantly Overvalued.

Key valuation signals for TSE:4556:

  • Asset Turnover: 0.29
  • GF Value™: 円1,281.99 vs. price of 円2,268.00 (76.9% above fair value)
  • GF Score™: 39/100 with 6 warning signs

No single metric tells the full story. See the TSE:4556 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


KAINOS Laboratories Business Description

Address 38-18, Hongo 2-chome, Bunkyo-ku, Tokyo, JPN
KAINOS Laboratories Inc is focused on the development, manufacture, marketing, distribution, and import/export of pharmaceuticals, diagnostic reagents, and related chemical products. It also manufactures, sells, and exports/imports physicochemical measuring equipment for medical use.
39GF Score

Get the complete analysis for TSE:4556

Asset Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円2,268.00
Price
円1,281.99
GF Value